Association of Sex With Toxic Effects, Treatment Adherence, and Oncologic Outcomes in the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trials of Rectal Cancer.

Diefenhardt, Markus; Ludmir, Ethan B; Hofheinz, Ralf-Dieter; Ghadimi, Michael; Minsky, Bruce D; Rödel, Claus; Fokas, Emmanouil

Diefenhardt, Markus; Ludmir, Ethan B; Hofheinz, Ralf-Dieter; Ghadimi, Michael; Minsky, Bruce D; Rödel, Claus; Fokas, Emmanouil.

Affiliation

Diefenhardt M; Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany.
Ludmir EB; Frankfurt Cancer Institute, Frankfurt, Germany.
Hofheinz RD; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Ghadimi M; Department of Medical Oncology, University Hospital Mannheim, Heidelberg University, Heidelberg, Germany.
Minsky BD; Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.
Rödel C; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Fokas E; Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany.

JAMA Oncol ; 6(2): 294-296, 2020 02 01.

Article in En | MEDLINE | ID: mdl-31804659

Subject(s)

Antimetabolites, Antineoplastic/adverse effects; Fluorouracil/adverse effects; Medication Adherence; Rectal Neoplasms/therapy; Sex Characteristics; Aged; Chemoradiotherapy, Adjuvant; Female; Humans; Male; Middle Aged; Prognosis; Rectal Neoplasms/mortality

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Rectal Neoplasms / Sex Characteristics / Medication Adherence / Fluorouracil / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: JAMA Oncol Year: 2020 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google